» Articles » PMID: 38397079

Epidemiology of Wilson's Disease and Pathogenic Variants of the Gene Leading to Diversified Protein Disfunctions

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Feb 24
PMID 38397079
Authors
Affiliations
Soon will be listed here.
Abstract

Wilson's disease (WD) is an autosomal recessive disorder characterized by toxic accumulation of copper in the liver, brain, and other organs. The disease is caused by pathogenic variants in the gene, which encodes a P-type copper transport ATPase. Diagnosing WD is associated with numerous difficulties due to the wide range of clinical manifestations and its unknown dependence on the physiological characteristics of the patient. This leads to a delay in the start of therapy and the subsequent deterioration of the patient's condition. However, in recent years, molecular genetic testing of patients using next generation sequencing (NGS) has been gaining popularity. This immediately affected the detection speed of WD. If, previously, the frequency of this disease was estimated at 1:35,000-45,000 people, now, when conducting large molecular genetic studies, the frequency is calculated as 1:7026 people. This certainly points to the problem of identifying WD patients. This review provides an update on the performance of epidemiological studies of WD and describes normal physiological functions of the protein and diversified disfunctions depending on pathogenic variants of the gene. Future prospects in the development of WD genetic diagnostics are also discussed.

Citing Articles

Evaluation of salivary ceruloplasmin for the diagnosis of Wilson's disease.

Zhang N, Wu L, Jiang P, Ji Z, Yin M, Zhou H Sci Rep. 2025; 15(1):8197.

PMID: 40065079 PMC: 11894043. DOI: 10.1038/s41598-025-93045-x.


Spectrum and classification of variants with clinical correlation in children with Wilson disease.

Al-Obaidi R, Al-Musawi B Saudi Med J. 2025; 46(2):131-142.

PMID: 39933775 PMC: 11822923. DOI: 10.15537/smj.2025.46.2.20240997.


Liver diseases: epidemiology, causes, trends and predictions.

Gan C, Yuan Y, Shen H, Gao J, Kong X, Che Z Signal Transduct Target Ther. 2025; 10(1):33.

PMID: 39904973 PMC: 11794951. DOI: 10.1038/s41392-024-02072-z.


Mechanisms of Copper-Induced Autophagy and Links with Human Diseases.

Fu Y, Zeng S, Wang Z, Huang H, Zhao X, Li M Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861161 PMC: 11768742. DOI: 10.3390/ph18010099.


Effect of primary copper metabolism disturbance on elemental, protein, and lipid composition of the organs in Jackson toxic milk mouse.

Hadrian K, Szczerbowska-Boruchowska M, Surowka A, Ciepiela O, Litwin T, Przybylkowski A Biometals. 2024; 38(1):103-121.

PMID: 39365499 PMC: 11754380. DOI: 10.1007/s10534-024-00640-y.


References
1.
Ferenci P, Stremmel W, Czlonkowska A, Szalay F, Viveiros A, Stattermayer A . Age and Sex but Not ATP7B Genotype Effectively Influence the Clinical Phenotype of Wilson Disease. Hepatology. 2018; 69(4):1464-1476. DOI: 10.1002/hep.30280. View

2.
Garcia-Villarreal L, Hernandez-Ortega A, Sanchez-Monteagudo A, Pena-Quintana L, Ramirez-Lorenzo T, Riano M . Wilson disease: revision of diagnostic criteria in a clinical series with great genetic homogeneity. J Gastroenterol. 2020; 56(1):78-89. DOI: 10.1007/s00535-020-01745-0. View

3.
Nilles C, Obadia M, Sobesky R, Dumortier J, Guillaud O, Laurencin C . Diagnosis and Outcomes of Late-Onset Wilson's Disease: A National Registry-Based Study. Mov Disord. 2022; 38(2):321-332. DOI: 10.1002/mds.29292. View

4.
Gomes A, Dedoussis G . Geographic distribution of ATP7B mutations in Wilson disease. Ann Hum Biol. 2015; 43(1):1-8. DOI: 10.3109/03014460.2015.1051492. View

5.
Li M, Ma J, Wang W, Yang X, Luo K . Mutation analysis of the ATP7B gene and genotype-phenotype correlation in Chinese patients with Wilson disease. BMC Gastroenterol. 2021; 21(1):339. PMC: 8411542. DOI: 10.1186/s12876-021-01911-5. View